Marigo Stathis

2.2k total citations
39 papers, 1.6k citations indexed

About

Marigo Stathis is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Surgery. According to data from OpenAlex, Marigo Stathis has authored 39 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 19 papers in Cellular and Molecular Neuroscience and 8 papers in Surgery. Recurrent topics in Marigo Stathis's work include Receptor Mechanisms and Signaling (12 papers), Neuroscience and Neuropharmacology Research (9 papers) and Neurotransmitter Receptor Influence on Behavior (9 papers). Marigo Stathis is often cited by papers focused on Receptor Mechanisms and Signaling (12 papers), Neuroscience and Neuropharmacology Research (9 papers) and Neurotransmitter Receptor Influence on Behavior (9 papers). Marigo Stathis collaborates with scholars based in United States, Czechia and Japan. Marigo Stathis's co-authors include Barbara S. Slusher, Camilo Rojas, Jesse Alt, Ajit G. Thomas, Ursula Scheffel, Sergio Cantoreggi, Silvia Sebastiani, Jie Zhang, Claudio Pietra and Takashi Tsukamoto and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Marigo Stathis

39 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marigo Stathis United States 22 588 534 299 274 195 39 1.6k
Jesse Alt United States 26 1.2k 2.0× 478 0.9× 248 0.8× 309 1.1× 884 4.5× 80 3.0k
Gene M. Williams United States 15 590 1.0× 159 0.3× 452 1.5× 656 2.4× 145 0.7× 18 1.7k
Mark Pierce United States 27 895 1.5× 300 0.6× 393 1.3× 337 1.2× 52 0.3× 51 2.1k
Ricardo Caballero Spain 34 1.6k 2.7× 138 0.3× 421 1.4× 180 0.7× 100 0.5× 103 2.8k
Edward Leung Italy 23 874 1.5× 172 0.3× 391 1.3× 168 0.6× 55 0.3× 36 1.8k
Anthony C. Sulpizio United States 22 750 1.3× 281 0.5× 411 1.4× 343 1.3× 29 0.1× 35 1.7k
Yasuhiko Iida Japan 23 474 0.8× 94 0.2× 171 0.6× 190 0.7× 142 0.7× 61 1.6k
Dirk Bender Denmark 27 382 0.6× 159 0.3× 360 1.2× 164 0.6× 111 0.6× 81 1.8k
Yutaka Hasegawa Japan 32 1.1k 1.8× 427 0.8× 146 0.5× 1.1k 4.1× 155 0.8× 99 3.1k
Gary G. Chicchi United States 29 1.5k 2.6× 374 0.7× 784 2.6× 219 0.8× 142 0.7× 65 2.5k

Countries citing papers authored by Marigo Stathis

Since Specialization
Citations

This map shows the geographic impact of Marigo Stathis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marigo Stathis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marigo Stathis more than expected).

Fields of papers citing papers by Marigo Stathis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marigo Stathis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marigo Stathis. The network helps show where Marigo Stathis may publish in the future.

Co-authorship network of co-authors of Marigo Stathis

This figure shows the co-authorship network connecting the top 25 collaborators of Marigo Stathis. A scholar is included among the top collaborators of Marigo Stathis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marigo Stathis. Marigo Stathis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ferrer, Marc, Sara J.C. Gosline, Marigo Stathis, et al.. (2018). Pharmacological and genomic profiling of neurofibromatosis type 1 plexiform neurofibroma-derived schwann cells. Scientific Data. 5(1). 180106–180106. 23 indexed citations
2.
Figuera-Losada, Mariana, Ajit G. Thomas, Marigo Stathis, et al.. (2017). Development of a primary microglia screening assay and its use to characterize inhibition of system xc- by erastin and its analogs. Biochemistry and Biophysics Reports. 9. 266–272. 15 indexed citations
3.
Rojas, Camilo, Marigo Stathis, Jennifer M. Coughlin, Martin G. Pomper, & Barbara S. Slusher. (2017). The Low-Affinity Binding of Second Generation Radiotracers Targeting TSPO is Associated with a Unique Allosteric Binding Site. Journal of Neuroimmune Pharmacology. 13(1). 1–5. 17 indexed citations
4.
Rais, Rana, Weiwei Jiang, Huihong Zhai, et al.. (2016). FOLH1/GCPII is elevated in IBD patients, and its inhibition ameliorates murine IBD abnormalities. JCI Insight. 1(12). 36 indexed citations
5.
Alt, Jesse, Marigo Stathis, Camilo Rojas, & Barbara S. Slusher. (2013). Glutamate carboxypeptidase II is not an amyloid peptide‐degrading enzyme. The FASEB Journal. 27(7). 2620–2625. 4 indexed citations
6.
Chen, Ying, Mrudula Pullambhatla, Sangeeta Ray Banerjee, et al.. (2012). Synthesis and Biological Evaluation of Low Molecular Weight Fluorescent Imaging Agents for the Prostate-Specific Membrane Antigen. Bioconjugate Chemistry. 23(12). 2377–2385. 82 indexed citations
7.
Alquicer, Glenda, David Sedlák, Youngjoo Byun, et al.. (2012). Development of a High-Throughput Fluorescence Polarization Assay to Identify Novel Ligands of Glutamate Carboxypeptidase II. SLAS DISCOVERY. 17(8). 1030–1040. 7 indexed citations
8.
Shukla, Krupa H., Dana Ferraris, Ajit G. Thomas, et al.. (2012). Design, Synthesis, and Pharmacological Evaluation of Bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl Sulfide 3 (BPTES) Analogs as Glutaminase Inhibitors. Journal of Medicinal Chemistry. 55(23). 10551–10563. 160 indexed citations
9.
Rojas, Camilo, Marigo Stathis, Michael Polydefkis, et al.. (2011). Glutamate carboxypeptidase activity in human skin biopsies as a pharmacodynamic marker for clinical studies. Journal of Translational Medicine. 9(1). 27–27. 8 indexed citations
10.
Rojas, Camilo, Ying Li, Jie Zhang, et al.. (2010). The Antiemetic 5-HT3 Receptor Antagonist Palonosetron Inhibits Substance P-Mediated Responses In Vitro and In Vivo. Journal of Pharmacology and Experimental Therapeutics. 335(2). 362–368. 108 indexed citations
11.
Grella, Brian, James F. Berry, Greg Delahanty, et al.. (2010). The discovery and structure–activity relationships of indole-based inhibitors of glutamate carboxypeptidase II. Bioorganic & Medicinal Chemistry Letters. 20(24). 7222–7225. 9 indexed citations
12.
Rojas, Camilo, Ajit G. Thomas, Jesse Alt, et al.. (2009). Palonosetron triggers 5-HT3 receptor internalization and causes prolonged inhibition of receptor function. European Journal of Pharmacology. 626(2-3). 193–199. 162 indexed citations
13.
Lever, John R., Ursula Scheffel, Marigo Stathis, et al.. (1996). Synthesis and in vivo studies of a selective ligand for the dopamine transporter: 3β-(4-[125I]iodophenyl) tropan-2β-carboxylic acid isopropyl ester ([125I]RTM-21). Nuclear Medicine and Biology. 23(3). 277–284. 18 indexed citations
14.
Stathis, Marigo, Ursula Scheffel, Sandra Lever, et al.. (1995). Rate of binding of various inhibitors at the dopamine transporter in vivo. Psychopharmacology. 119(4). 376–384. 68 indexed citations
15.
Kassiou, Michael, Ursula Scheffel, John L. Musachio, Marigo Stathis, & R. F. Dannals. (1995). [3H]A-69024: A non-benzazepine ligand for in vitro and in vivo studies of dopamine d1 receptors. Life Sciences. 57(23). PL367–PL372. 3 indexed citations
16.
Musachio, John L., Ursula Scheffel, Marigo Stathis, et al.. (1994). (+)-[C-11]-cis-N-benzyl-normetazocine: A selective ligand for sigma receptors in vivo. Life Sciences. 55(11). PL225–PL232. 22 indexed citations
17.
Wilson, Alan A., Ursula Scheffel, R. F. Dannals, et al.. (1991). In vivo biodistribution of two [18F]-labelled muscarinic cholinergic receptor ligands: 2-[18F]- and 4-[18F]-fluorodexetimide. Life Sciences. 48(14). 1385–1394. 15 indexed citations
18.
Lever, John R., Ursula Scheffel, John L. Musachio, Marigo Stathis, & Henry N. Wagner. (1991). Radioiodinated D-(+)-N1-ethyl-2-iodolysergic acid diethylamide: A ligand for in vitro and in vivo studies of serotonin receptors. Life Sciences. 48(15). PL73–PL78. 5 indexed citations
19.
Scheffel, Ursula, J.W. Boja, Marigo Stathis, & M J Kuhar. (1990). In vivo labeling of cocaine receptors with sup 3 H-(-) cocaine, sup 3 H-WIN 35,065-2 and sup 3 H-WIN 35,428. 1 indexed citations
20.
Lever, John R., Ursula Scheffel, Marigo Stathis, John L. Musachio, & Henry N. Wagner. (1990). In vitro and in vivo binding of (E)- and (Z)-N-(iodoallyl)spiperone to dopamine D2 and serotonin 5-HT2 neuroreceptors. Life Sciences. 46(26). 1967–1976. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026